Literature DB >> 12958366

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China.

Y Guan1, B J Zheng, Y Q He, X L Liu, Z X Zhuang, C L Cheung, S W Luo, P H Li, L J Zhang, Y J Guan, K M Butt, K L Wong, K W Chan, W Lim, K F Shortridge, K Y Yuen, J S M Peiris, L L M Poon.   

Abstract

A novel coronavirus (SCoV) is the etiological agent of severe acute respiratory syndrome (SARS). SCoV-like viruses were isolated from Himalayan palm civets found in a live-animal market in Guangdong, China. Evidence of virus infection was also detected in other animals (including a raccoon dog, Nyctereutes procyonoides) and in humans working at the same market. All the animal isolates retain a 29-nucleotide sequence that is not found in most human isolates. The detection of SCoV-like viruses in small, live wild mammals in a retail market indicates a route of interspecies transmission, although the natural reservoir is not known.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958366     DOI: 10.1126/science.1087139

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  997 in total

1.  Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.

Authors:  Matthew Frieman; Boyd Yount; Sudhakar Agnihothram; Carly Page; Eric Donaldson; Anjeanette Roberts; Leatrice Vogel; Becky Woodruff; Diana Scorpio; Kanta Subbarao; Ralph S Baric
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Why SARS will not return: a polemic.

Authors:  Donald E Low
Journal:  CMAJ       Date:  2004-01-06       Impact factor: 8.262

Review 3.  Response of the clinical microbiology laboratory to emerging (new) and reemerging infectious diseases.

Authors:  Franklin R Cockerill; Thomas F Smith
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

4.  Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis.

Authors:  Z F Sun; X J Meng
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

5.  Confronting SARS: a view from Hong Kong.

Authors:  J S M Peiris; Y Guan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-07-29       Impact factor: 6.237

6.  Severe acute respiratory syndrome coronavirus phylogeny: toward consensus.

Authors:  Alexander E Gorbalenya; Eric J Snijder; Willy J M Spaan
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 7.  Severe acute respiratory syndrome (SARS): epidemiology and clinical features.

Authors:  D S C Hui; M C H Chan; A K Wu; P C Ng
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

8.  The impact of the SARS epidemic on the utilization of medical services: SARS and the fear of SARS.

Authors:  Hong-Jen Chang; Nicole Huang; Cheng-Hua Lee; Yea-Jen Hsu; Chi-Jeng Hsieh; Yiing-Jenq Chou
Journal:  Am J Public Health       Date:  2004-04       Impact factor: 9.308

9.  SARS related preventive and risk behaviours practised by Hong Kong-mainland China cross border travellers during the outbreak of the SARS epidemic in Hong Kong.

Authors:  Joseph T F Lau; Xilin Yang; H Y Tsui; Ellie Pang
Journal:  J Epidemiol Community Health       Date:  2004-12       Impact factor: 3.710

10.  Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry.

Authors:  Dong P Han; Motashim Lohani; Michael W Cho
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.